Prescription Required 
India
Ezetimibe is a medication primarily used to lower cholesterol levels in the blood. It works by inhibiting the absorption of cholesterol from the intestines, which helps reduce the amount of cholesterol that enters the bloodstream. This action can lead to a significant decrease in low-density lipoprotein (LDL) cholesterol, often referred to as "bad" cholesterol.
Ezetimibe is a cholesterol-lowering medication that works by reducing cholesterol absorption in the small intestine. It is commonly prescribed to lower low-density lipoprotein (LDL-C) levels and is often used alone or in combination with statins to manage hypercholesterolemia and reduce cardiovascular risk.
Other Popular Names
Ezetimibe is available under various brand names, including:
- Zetia (widely recognized brand)
- Ezedoc
- Ezemibe
- Ezent
- Liptruzet (combination with Atorvastatin)
Uses of Ezetimibe
Ezetimibe is primarily prescribed for:
- Lowering high cholesterol levels (hypercholesterolemia)
- Reducing the risk of cardiovascular diseases
- Managing familial hypercholesterolemia (FH), often in combination with a statin
- Supporting cholesterol control in patients intolerant to statins
Benefits of Ezetimibe
- Significant LDL-C Reduction: Lowers LDL-C by 18–25% when used alone and up to 50–60% when combined with a statin.
- Alternative to Statins: Suitable for individuals who cannot tolerate statins due to muscle-related side effects.
- Combination Therapy Advantage: Enhances the cholesterol-lowering effect of statins, allowing for lower statin doses.
- Minimal Systemic Absorption: Primarily acts in the intestine, reducing systemic side effects.
Contraindications
Ezetimibe is not recommended for individuals with:
- Moderate to severe liver disease
- Pregnancy or breastfeeding (unless advised by a healthcare professional)
- Known hypersensitivity to Ezetimibe or its components
- Active gallbladder disease, especially when taken with fibrates
Dosage and Administration
- Adults: 10 mg once daily (with or without food)
- Children (≥10 years old): 10 mg once daily for familial hypercholesterolemia
- Combination Therapy: Frequently prescribed with statins such as Atorvastatin or Simvastatin for enhanced cholesterol control
Ezetimibe is intended for long-term use under medical supervision.
Mechanism of Action
Ezetimibe selectively inhibits the Niemann-Pick C1-Like 1 (NPC1L1) protein, which is responsible for cholesterol absorption in the small intestine. By blocking this pathway, it reduces the amount of cholesterol entering the bloodstream, thereby lowering LDL-C levels.
Potential Side Effects
While generally well-tolerated, some individuals may experience:
Common Side Effects:
- Headache
- Fatigue
- Diarrhea
- Upper respiratory tract infections
Rare but Serious Side Effects:
- Elevated liver enzymes (especially when taken with statins)
- Muscle pain (myopathy/rhabdomyolysis)
- Severe allergic reactions (rash, swelling, difficulty breathing)
Missed Dose Guidance
If a dose is missed, it should be taken as soon as remembered. However, if the next scheduled dose is near, the missed dose should be skipped. Double dosing should be avoided.
Drug Interactions
Ezetimibe may interact with:
- Statins (Simvastatin, Atorvastatin): Increased risk of liver toxicity and muscle-related side effects.
- Fibrates (Gemfibrozil): Higher risk of gallstones and muscle toxicity.
- Warfarin: May enhance anticoagulant effects, requiring close monitoring of INR levels.
- Bile Acid Sequestrants (Cholestyramine): Reduces Ezetimibe absorption; should be taken at least 2 hours before or 4 hours after.
Long-Term Safety and Monitoring
- Clinical trials confirm long-term safety and efficacy of Ezetimibe.
- Regular cholesterol monitoring is recommended.
- Liver function tests may be required when taken with statins.
Recent Clinical Research on Ezetimibe
- IMPROVE-IT Trial (2015): Demonstrated that adding Ezetimibe to Simvastatin significantly reduced cardiovascular events in patients with acute coronary syndrome.
- FOURIER Trial (2017): Showed additional benefits when used alongside PCSK9 inhibitors for high-risk patients.
- Meta-analysis (2023): Found that Ezetimibe effectively lowers LDL-C levels with a favorable safety profile.
References
- Cannon CP et al. IMPROVE-IT Trial, N Engl J Med. 2015;372(25):2387-2397.
- Sabatine MS et al. FOURIER Trial, N Engl J Med. 2017;376(18):1713-1722.
- Taylor F et al. Meta-analysis of Ezetimibe use, JAMA Cardiology, 2023.
Availability
Ezetimibe is available by prescription only and should be taken under the guidance of a healthcare professional.
Best Practices for Optimal Cholesterol Control
- Maintain a heart-healthy diet rich in fiber and low in saturated fats.
- Engage in regular physical activity (at least 150 minutes per week).
- Avoid smoking and excessive alcohol consumption.
- Regularly monitor cholesterol levels and liver function tests.
Conclusion
Ezetimibe is an effective and well-tolerated cholesterol-lowering agent, particularly beneficial for patients who require additional LDL-C reduction or cannot tolerate statins. Its role in cardiovascular risk management is well-supported by clinical trials, making it a valuable treatment option when used as part of a comprehensive cholesterol-lowering strategy.
For more information or to order Ezetimibe, consult a licensed pharmacist or healthcare provider at WalDrugMart Online Pharmacy.
Write Your Own Review